{
    "code": "52027801",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027801",
    "time": "2020-11-27 10:40:52",
    "許可證字號": "衛部藥輸字第027801號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/02\/03",
    "發證日期": "109\/02\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202780102",
    "中文品名": "達勝癌膠囊0.25毫克",
    "英文品名": "Talzenna Capsules 0.25 mg",
    "適應症": "TALZENNA單一療法適用於治療曾接受前導性、術後輔助性或轉移性化療，或無法接受化療，且具生殖細胞BRCA 1\/2 (germline BRCA 1\/2)突變併HER2 陰性之局部晚期或轉移性乳癌成年病人。",
    "劑型": "130膠囊劑",
    "包裝": "8-1000粒PVC\/PVdC鋁箔盒裝、塑膠瓶裝(HDPE)",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "114\/02\/03",
    "主成分略述": "Talazoparib Tosylate",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0929101100  美商惠氏藥廠（亞洲）股份有限公司台灣分公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0364100  EXCELLA GMBH &amp; CO. KG",
            "製造廠廠址": "NURNBERGER STR. 12, 90537 FEUCHT, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1005000100",
            "成分名稱": "Talazoparib Tosylate",
            "含量描述": "(0.363 mg of talazoparib tosylate is equivalent to 0.25 mg of talazoparib active moiety (free base).)",
            "含量": "0.3630000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "0604-Talzenna 達勝癌膠囊 中文仿單_748x352mm-outline-109-07-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027801&Seq=003&Type=9"
        },
        {
            "title": "Talzenna_0.25mg_Bottle-109-07-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027801&Seq=002&Type=8"
        },
        {
            "title": "Artwork - Talzenna cap 0.25mg-109-02-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027801&Seq=001&Type=8"
        }
    ]
}